Goal is an analysis of the assortment of anti-inflammatory and anti-rheumatic medicines presented on the pharmaceutical market of Ukraine, and substantiation of market opportunities for domestic manufacturers. Materials and methods. The research materials are data from the State Register of Medicines of Ukraine and the online directory of medicines Compendium, publications of scientific and practically-oriented medical and pharmaceutical publications. The methods of office marketing research, comparative analysis, logical summarization of results, and the graphic method were used for achieving the goal. Results of the research. During the study, the structure of the assortment of anti-inflammatory and anti-rheumatic medicines and the characteristic trends for the registration of new medicines on the domestic pharmaceutical market were determined. It has been established that in 2022, 463 trade names will be registered on the domestic pharmaceutical market. The assortment of anti-inflammatory and anti-rheumatic medicines was analyzed by active substance, release form, producing countries, and the possibility of use in pediatrics. Prospective directions for updating the product assortment of anti-inflammatory and anti-rheumatic medicines of domestic production have been determined. Conclusions. According to the results of the study, it was found that the group of anti-inflammatory and anti-rheumatic medicines is represented by a wide assortment, however, the market is characterized by import dependence, which has a negative impact on the medical supply of certain categories of consumers. Prospective segments on the market of anti-inflammatory and anti-rheumatic medicines for domestic manufacturers have been established.

Aim. To conduct the marketing research of the pharmaceutical market of Ukraine in the segment of medicinal products (MP) used for the treatment and prevention of infections caused by HSV-1 and HSV-2. Materials and methods. To achieve this aim, methods of logical and meaningful problem formation, desk marketing research, content analysis of publications in scientific and practice-oriented medical and pharmaceutical literature, comparative analysis were used. Results. The paper presents the results of the marketing analysis of the Ukrainian pharmaceutical market of antiherpetic MP. For the study, according to the ATC classification, 5 groups of medicines registered at the domestic market were selected. In the drug package leaflets for these medicines herpes infection was one of the indications for use. As of October 1, 2021, the range of antiherpetic MP includes 194 trade names for systemic and local use. The market segmentation of these groups of medicines by manufacturing countries, drug form, conditions of dispensing, origin and composition was carried out. It has been found that the share of herbal medicinal products is 14.43 % (6 positions) and is represented by products for systemic use. Conclusions. The research of the market of antiherpetic medicines conducted can be considered as the basis for the search and development of new effective antiviral herbal medicinal products of domestic production for the local treatment of the herpes virus.